2 results match your criteria: "Cardiovascular Center Aalst OLV Hospital Aalst Belgium.[Affiliation]"
Article Synopsis
- * A systematic review of 56 studies found that about 41% of patients had CMD, 40% had epicardial vasospasm, and 24% experienced microvascular spasm, with women at higher risk for CMD.
- * The findings highlight the need for increased awareness among healthcare providers regarding ischemic conditions in patients without obstructive coronary arteries to ensure accurate diagnoses and appropriate treatments.
Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
Res Pract Thromb Haemost
October 2018
Laboratory for Thrombosis Research IRF Life Sciences KU Leuven Campus Kulak Kortrijk Kortrijk Belgium.
Background: Patients with von Willebrand disease (VWD) type 2A or acquired von Willebrand syndrome (aVWS) as a consequence of implantation of left ventricular assist devices (LVAD) are both characterized by a loss of von Willebrand factor (VWF) function. Loss of VWF function is however more severe in VWD type 2A than in LVAD patients.
Objectives: To compare VWF function in patients with VWD type 2A and LVAD-induced aVWS to highlight the differences in VWF activity and to stress the importance of VWF multimer analysis for correct diagnosis of aVWS in LVAD patients.